Can a clot-preserving drug stop bleeding in blood cancers?
NCT ID NCT06599762
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 33 times
Summary
This study tests whether tranexamic acid, a medicine that helps blood clots stay in place, can reduce bleeding in people with myelodysplastic syndromes or acute myeloid leukemia who are on chemotherapy. About 75 adults with low platelet counts will be randomly assigned to receive either the drug or a placebo. The main goal is to see if it's possible to enroll enough patients, while also checking for safety and whether bleeding episodes decrease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CancerCare Manitoba
RECRUITINGWinnipeg, Manitoba, R3E 0V9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.